11:15 AM EST, 12/18/2024 (MT Newswires) -- Akari Therapeutics ( AKTX ) said Wednesday it has named Samir Patel chief executive, effective Dec. 16.
Patel served as interim CEO of Akari Therapeutics ( AKTX ) since May. He currently serves as founder and principal of PranaBio Investments.
Price: 1.01, Change: +0.01, Percent Change: +1.01